Advertisement
Advertisement

HIV Spotlight on Center on Caring for the Newly Diagnosed Patient

Feature

What's New or Notable in HIV Treatment and Prevention Adherence?

July 20, 2017

 3/8 

Leo Moore, M.D.

Leo Moore, M.D.

Los Angeles County Department of Public Health

There are a few things that were key to me. One was a study that was done through the University of California San Diego, where they looked at meth use and the association with PrEP adherence: They found no significant association between meth use and PrEP non-adherence.

I get a lot of providers saying things like, "Oh, a patient's not going to take their PrEP if they're on meth," or "They're not going to be adherent to PrEP because they have substance use on board."

So, I think this is a great study to be able to use in those conversations: Every patient, although they may be using other substances, may still find time to take their PrEP -- and be able to decrease their risk of HIV.

Image credit: Olivia G. Ford.







No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.